We investigate the biology of adult stem cells, immune cells, endothelial precursors and fibroblasts as well as their possible role in musculoskeletal tissue regeneration.

We investigate the molecular and cellular bases of clinically relevant questions in musculoskeletal surgery, focusing on pharmacologically exploitable signaling events.

After an injury, bone can usually heal. However, despite good medical care, 5-20% of all fractures take a long time to heal or fail to heal at all. The aim of our research is to find a meaningful solution strategy for these patients.

In addition to bone regeneration, the aim of our working group is to better understand tendon regeneration and thus to develop therapies for the patient that are improved in perspective.

Since 2006 we have been working on translational therapies in the field of musculoskeletal regeneration with the aim to bring innovative regenerative approaches to the patient.